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An integrated whole genome 
analysis of Mycobacterium 
tuberculosis reveals insights into 
relationship between its genome, 
transcriptome and methylome
paula J. Gomez-Gonzalez1, Nuria Andreu  1, Jody e. phelan  1, paola Florez de sessions2, 
Judith R. Glynn  3, Amelia C. Crampin3,4, susana Campino1, philip D. Butcher5, 
Martin L. Hibberd1,2 & taane G. Clark  1,3
Human tuberculosis disease (tB), caused by Mycobacterium tuberculosis (Mtb), is a complex 
disease, with a spectrum of outcomes. Genomic, transcriptomic and methylation studies have 
revealed differences between Mtb lineages, likely to impact on transmission, virulence and drug 
resistance. However, so far no studies have integrated sequence-based genomic, transcriptomic and 
methylation characterisation across a common set of samples, which is critical to understand how 
DNA sequence and methylation affect RNA expression and, ultimately, Mtb pathogenesis. Here we 
perform such an integrated analysis across 22 M. tuberculosis clinical isolates, representing ancient 
(lineage 1) and modern (lineages 2 and 4) strains. The results confirm the presence of lineage-specific 
differential gene expression, linked to specific SNP-based expression quantitative trait loci: with 10 
eQTLs involving SNPs in promoter regions or transcriptional start sites; and 12 involving potential 
functional impairment of transcriptional regulators. Methylation status was also found to have a role 
in transcription, with evidence of differential expression in 50 genes across lineage 4 samples. Lack 
of methylation was associated with three novel variants in mamA, likely to cause loss of function of 
this enzyme. overall, our work shows the relationship of DNA sequence and methylation to RNA 
expression, and differences between ancient and modern lineages. Further studies are needed to verify 
the functional consequences of the identified mechanisms of gene expression regulation.
Human tuberculosis disease (TB), caused by Mycobacterium tuberculosis (Mtb), is a major global public health 
issue1. A deeper understanding of the biology of Mtb should reveal new insights that may help to improve diag-
nostics, treatments, vaccines and other much needed control measures. Mtb belongs to the M. tuberculosis com-
plex (MTC), which consists of seven main lineages classified into modern (lineages 2–4), ancient (lineages 1, 5 
and 6), and intermediate (lineage 7) strains2. The lineages vary in their geographic distribution and spread, with 
lineage 2 being particularly mobile with evidence of recent spread from Asia to Europe and Africa. Lineage 4 is 
common in Europe and southern Africa, coinciding with regions of high TB incidence and high levels of HIV 
co-infection. The lineages may vary in their propensity to transmit and to cause disease, and in the site and sever-
ity of disease3–5. A set of SNPs in the Mtb genome (size 4.4 Mb) has been identified that can be used to barcode 
sub-lineages6, leading to informatic tools that position sequenced samples within a global phylogeny7.
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Genetic diversity, accessible through whole genome sequencing, plays an important role also in transcrip-
tion. Gene expression differences have been observed, with 15% of the genes found to be differentially expressed 
among different Mtb clinical isolates8, and lineage-specific transcriptome differences have been observed in vitro 
and during survival in macrophages9,10. The mechanisms controlling expression of candidate genes, such as the 
upregulation of the dosR operon specific to Beijing strains, have been broadly investigated11–13. However, little 
is known about the effect of genomic variation on transcription at a whole genome scale. These effects can be 
explored through an association analysis of polymorphisms, such as single nucleotide polymorphisms (SNPs), 
and gene expression levels to determine expression quantitative trait loci (eQTL). eQTLs are genetic variants that 
explain variation in gene expression levels, and can be classified as cis or trans depending on the physical distance 
from the gene they regulate14. In Mtb, one previous study focusing on lineage 1 and 2 strains, highlighted two 
types of mechanisms where polymorphisms may change gene expression: through impairment of transcriptional 
regulators or by affecting the promoter regions10.
In addition to genomic variants, epigenetic mechanisms such as DNA methylation have an effect on gene 
expression. Several lines of evidence have revealed N6-methyladenine (m6A) and 5-methylcytosine (m5C) meth-
ylation mechanisms within Mtb genomes, and these can be characterised using single-molecule real time (SMRT) 
sequencing from Pacific Biosciences technology15,16. Motifs within three DNA methyltransferases (MTases), 
mamA, mamB, and hsdM are responsible for m6A modification15–17. In Mtb it has been shown that the loss of 
mamA MTase can decrease gene expression and affect survival during hypoxia17. Methylation sites have been 
found to overlap with sigma factor binding sites, suggesting that if methylation affects sigma factor binding, 
methylation status may play a role in transcription17. Lineage-specific methylation patterns have been reported 
for Mtb strains16, which indicates the potential for novel functional differences between them. In eukaryotic cells, 
DNA methylation is often associated with repression of gene expression; however, in prokaryotes, methylation 
has been associated with both induction and repression of gene expression17,18.
To date, no studies have integrated sequence-based genomic, transcriptomic and methylation characterisation 
across a common set of samples. This integration is critical to understand how DNA sequence and methylation 
affect RNA expression and, ultimately, Mtb pathogenesis. Here we seek to investigate the relationship between the 
genome, transcriptome and methylome in a panel of 22 Mtb isolates, belonging to the Karonga Prevention Study, 
a longitudinal epidemiological project focused on mycobacterial disease19. We present a differential gene expres-
sion study correlated with lineage, as well as an eQTL study linked with SNPs and methylated bases at a whole 
genome scale. Differential transcription between lineages was found, and genetic variants revealed as potential 
candidate eQTLs. Methylation status was also found to have a potential role in transcription, with evidence of 
differential gene expression between samples with non-methylated and methylated genes.
Results
Genomic analysis. Mtb was isolated from 22 sputum samples from 22 different TB patients collected 
between 2003 and 2009 in Karonga, a northern district of Malawi. The majority of individuals were HIV pos-
itive (16/22). Genomic DNA was extracted and sequenced using PacBio single-molecule real time (SMRT) and 
Illumina sequencing technologies. One ancient (L1, n = 8) and two modern lineages (L2 and L4, n = 14) were 
represented (Supplementary Table S1). For each isolate, the raw sequence data was aligned to the H37Rv reference 
genome, leading to >100-fold average coverage. Across all samples 9,384 unique SNPs were characterised, with 
~40% of them identified in single isolates. Only 1,446 of the 9,384 SNPs were located in intergenic regions. The 
average number of SNPs per isolate varied by lineage (L1: 2,613; L2: 1,675; L4: 1,101); the sub-lineage 4.9 (H37Rv-
like) was the least polymorphic (~600 variants). Using the 9,384 SNPs, a maximum-likelihood phylogenetic tree 
was constructed (Fig. 1) and the isolates clustered by lineage as expected.
Transcriptomic analysis and lineage-specific expression. Mtb RNA was extracted from the 22 clin-
ical isolates following liquid culture at mid-log phase growth and sequenced using Illumina HiSeq technology. 
Short reads were aligned to the H37Rv reference genome and counts per gene were obtained. A total of 3,987 
genes were transcribed in at least two clinical isolates with a minimum of 10 counts. The average number of tran-
scripts in the sample set is 3,864. A differential expression test was performed by clade, between the ancient (L1; 
n = 8) and the modern (L2 and L4; n = 14) strains in our sample set (Supplementary Fig. S1A). At a significance 
level of p < 1.24 × 10−5 (corresponding to a Bonferroni adjusted p < 0.05), 105 genes were revealed as differ-
entially expressed (Fig. 2, Supplementary Table S2). Five of them (Rv1524-wbbL2, Rv2652c-Rv2653c-Rv2658c) 
correspond to known deletions in ancient isolates. PE_PGRS57 was also absent in ancient genomes of our sam-
ples, which has also been observed to be deleted in other ancient (L5; M. Africanum) strains in other studies20,21. 
As expected, Rv1524-wbbL2, Rv2652c-Rv2653c-Rv2658c and PE_PGRS57 transcripts were down-regulated in 
ancient strains. Forty-eight of the 105 (45.7%) genes found to be differentially expressed by clade have been 
reported in previous transcriptomic analyses performed between ancient and modern strains or L1 and L29,10, 
leading to 57 newly described genes here. The main functional ontological categories for the 105 identified genes 
were conserved hypotheticals and intermediary metabolism and respiration. Enrichment in nitrogen metabo-
lism (p = 2.75 × 10−5) and PE-PGRS (p = 7.2 × 10−3) associated genes was found. Within clade-specific patterns, 
genes associated with transcriptional regulation were also identified. For ancient strains, Rv0273c, Rv0275c, and 
Rv2160A were the most under-expressed, whilst pknH, Rv2282c, virS, and Rv3167c, were over-expressed. In addi-
tion, several of the 105 differentially expressed genes were associated with virulence. Three of them belonged 
to the vapBC toxin-antitoxin system (vapB10, vapC10, vapB22), which were up- or down-regulated in ancient 
strains. Also, the mce4A gene, involved in cholesterol uptake during macrophage survival and associated with 
long term persistence22, and yrbE4B, forming part of the mce4 operon, were found over-expressed in ancient 
isolates. Finally, genes associated with drug resistance, such as the efflux pump Rv2994 and the isoniazid related 
iniA and iniB genes, were revealed as differentially expressed between the ancient and modern lineages studied. 
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Rv2994 has found to be over-expressed in multi-drug resistant isolates23, and the iniA and iniB genes are related 
with higher persistence under isoniazid conditions24,25.
Identification of Expression Quantitative Trait Loci (eQTL). An eQTL analysis was performed at a 
whole genome scale across the 22 isolates, and we attempted to associate SNP alleles with differential transcrip-
tion signal. Association testing was performed between 9,384 SNPs and 3,987 transcripts using a linear regression 
modelling approach (Supplementary Fig. S1B). We identified potential eQTLs from the 38,949 significant asso-
ciations between 5,608 SNP positions and 118 differential transcribed genes (p < 1.32 × 10−9; adjusted p < 0.05). 
The 5,608 SNPs considered as eQTLs were located in 2,279 genes and intergenic regions. Forty-two of the 118 
(35.6%) genes were differentially expressed due to large deletions and were subsequently excluded from fur-
ther analysis (Supplementary Table S3), leaving 76 genes as potentially affected by SNP eQTLs (Supplementary 
Table S4). More than half of these 76 genes had a lineage or sub-lineage-specific expression profile. Moreover, a 
large number of the eQTLs associations were due to both lineage-specific SNPs and expressed genes. Thereby, a 
group of 790 common SNPs across all ancient isolates was associated with the expression of 24 genes; a group of 
169 SNPs present in all L1 and L2 isolates was associated with the expression of 9 genes, and 584 SNPs present in 
Beijing (L2) isolates were associated with the expression of 3 genes (Supplementary Table S4). To assign the most 
likely causative genetic variation of the eQTLs, we investigated SNPs with a potential cis regulatory function and 
those within transcriptional regulatory proteins.
Cis-regulatory eQTLs. A cis-eQTL analysis was performed at SNPs, within each gene or < 200 bp upstream from 
their start codon, tested for differential expression (Supplementary Fig. S1C). This analysis identified 99 potential 
cis-eQTLs associated with the differential expression of 83 genes (p < 4.04 × 10−6, adjusted p < 0.05), involving 
92 SNPs (Supplementary Table S5). The majority (65/92) of these candidate cis-eQTL SNPs were located within 
the gene, 15 were located in the upstream intergenic region and 8 within the upstream gene. Among those in the 
upstream intergenic region, 8 were in predicted promoter regions. Eleven upstream SNPs (11/15) were common 
(allele frequency >5%) in a global set of strains (n = 6,218)26. Also, 6 SNPs within the upstream gene (6/8) were 
common (Table 1). Among them, the antitoxin vapB22, is known to be over-expressed in ancient isolates when 
compared to modern strains, and was found to harbour a SNP in its promoter (T3137237C) in all ancient isolates, 
thereby providing a possible explanation for the change in expression. Further, all the SNPs identified as potential 
cis-eQTLs were aligned to a map of transcriptional start sites (TSS)27. We found that three were located within 
the TSS of three genes shown to be differentially expressed in L1 compared to modern strains, with PE_PGRS38 
(A2424864G) and fadD31 (T2177073C) under-expressed, and virS (A3447480C) over-expressed in ancient iso-
lates. Overall, five SNPs present in ancient strains identified in this study as potential cis-eQTLs have already been 
reported as potentially associated with variation in gene transcription10, giving us confidence in our approach.
Transcriptional regulatory proteins. We next considered candidate SNP eQTLs with non-synonymous muta-
tions in transcriptional regulatory proteins (Supplementary Fig. S1D). These mutations could affect the DNA 
binding function of the protein. In total, 46 SNPs in 38 different transcriptional regulatory proteins (Table 2) 
were associated in the eQTL analysis with the differential transcription of 56 genes, accounting for a total of 376 
potential eQTL associations. Ten of these 46 SNPs have been previously reported as having a potential effect in 
transcriptional regulation10. Functional effects were investigated through the SIFT algorithm, and 16 of the 38 
(42.1%) transcriptional regulators were predicted to have SNP mutations affecting functional impairment. For 
Figure 1. Phylogenetic tree of the 22 Karonga strains. Maximum-likelihood phylogenetic tree of the 22 isolates 
analysed, covering lineages 1 (L1), 2 (L2) and 4 (L4).
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the majority of the regulatory genes (20/38; 52.6%), the SIFT software did not predict a functional consequence 
of the mutations, due to the lack of homology with sequences in its database.
Mutations in the sirR and Rv0195 genes resulted in stop codons and led to truncated proteins. The stop codon 
in sirR, a manganese-dependent transcriptional repressor28, was observed in all L1 samples. While, mutations 
in Rv0195, a LuxR family regulatory gene, were observed in one L1 sample. Some of the 38 transcriptional reg-
ulators belonged to other known regulatory families such as TetR. The TetR family of transcriptional regulators 
(TFTRs) are one-component prokaryotic signal transduction systems controlling different biochemical functions. 
Although they were thought to be expression repressors, work in other bacteria has shown that they can act also as 
activators29. The TFTR Rv2160A carried a SNP (C155R) and an insertion (304insGGAA) causing a change in the 
Figure 2. Gene expression differences between modern (lineage 2 and 4) and ancient (lineage 1) strains. A 
heatmap showing the 105 genes differentially expressed between ancient and modern strains, constructed 
with the gene expression distances between rows. Rows and columns are ordered based on row or column 
means. Over-expressed genes are coloured in red whilst under-expressed ones in green. Ancient strains (n = 8) 
represented on the left of the white vertical line and modern strains (n = 14) on the right. Lineage 1 represented 
in violet, Lineage 2 in blue and Lineage 4 in red.
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reading frame in isolates from L1 and L2. Rv2160A is likely to form part of the operon Rv2159c/Rv2160A/Rv2161c. 
In our analysis, Rv2159c and Rv2161c were revealed as highly down-regulated in ancient strains compared to 
modern ones, and marginally down-regulated in L2 compared to L4 isolates. These observations suggest the 
operon may act as an activator, and that the mutations may lead to a loss of its function.
In Streptomyces it has been shown that TFTRs can regulate divergently oriented neighbouring genes30, and 
previous studies in Mtb10,31 have found differential expression of genes adjacent to TFTRs. We looked for sim-
ilar effects in Mtb TFTRs carrying potential eQTLs. Rv0275c is a potential regulator of its divergent oriented 
neighbouring gene Rv0276. The ancient strains carried a mutation (S24L) in Rv0275c, which was associated with 
the under-expression of Rv0276. Similarly, Rv3167c is a potential regulator of its divergent oriented neighbour 
gene Rv3168. Although, the ancient strains carried a mutation (P17Q) in Rv3167c, and Rv3168 appeared slightly 
over-expressed, this effect did not reach the stringent significance cut off imposed in the eQTL analysis.
In order to study the consequential effects of mutations in the transcriptional regulators of the genes found 
as being differentially expressed, network gene regulation was analysed through the Environment and Gene 
Regulatory Influence Network (EGRIN) model from the MTB Network Portal32 and the regulatory network 
map from the TB database33. We compared the predicted induced and repressed genes by the transcriptional 
regulators harbouring non-synonymous SNPs with the differentially expressed genes in our samples. This anal-
ysis revealed the association of genes differentially expressed with five of our candidate transcriptional regu-
lators (Supplementary Table S6). Rv0275c, which is predicted to auto-induce its expression, was found to be 
down-regulated in ancient strains (with S24L mutation), although this effect did not reach the statistical sig-
nificance cut-off. In addition to the under-expression of Rv0276, discussed above, three other genes (Rv0520, 
Rv2162c and Rv0826) were found to be under-expressed in ancient strains and are predicted to be regulated 
by Rv0275c. Genes regulated by ramB, were up- or down-regulated in ancient strains carrying ramB P91Q and 
Q121R mutations. Other genes were regulated by the transcriptional regulators Rv1776c, Rv3167c and Rv3249c, 
which harboured potential impairment mutations, leading to under- or over-expression in those isolates carrying 
the mutations. For the remaining regulators within known control networks, no statistically significant associa-
tions of variable gene expression with mutations were found.
Sigma and anti-sigma factors are critical to the gene expression regulatory network34, and here we hypoth-
esised that polymorphisms in these factors might affect the transcription of those genes regulated by them. We 
found three anti-sigma factors (rseA, rskA and rsfA) harbouring non-synonymous SNPs that were considered as 
potential eQTLs (adjusted p < 0.05) associated with six genes differentially expressed between the isolates carry-
ing and not carrying the mutations (Supplementary Table S7).
Transcript 
differentially 
expressed Annotation SNP
Position SNP
Regulation
Strain
Lineage
Allele frequency**
Gene
Distance (bp) 
from start 
codon
Promoter 
(P)/TSS Ancient Modern
SNPs in 
upstream 
region
Rv0193c 1 G226676A IGR −105 — Up 1 0.973 0
Rv0326 — T392261C Rv0325 −12 — Up 1,2 0.978 0.324
Rv0377 6 T454295C Rv0376c −126 — Up 1,2,4.1,4.3.4, 4.8,4.9 1 0.994
gpdA1 4 T655986G IGR −37 P Up 1,2 0.976 0.324
mce2D 6 A690450C mce2C −51 — Up 1,2 0.976 0.324
Rv0669c 3 T769663G IGR −66 P Down 4.3.3 0 0.050
Rv0958 3 C1069871T IGR −12 P Up 1.1.3 0.220 0
Rv1096 3 T1224367C IGR −18 P Down 1,2,4.1,4.3,4.8 1 0.976
Rv1503c 1 A1694547C IGR −3 — Up 1 0.973 0
fadD31 4 T2177073C IGR −14 TSS/P Down 1 0.973 0
Rv2036 3 C2282058T Rv2035 −41 — Up 1.2.2* 0.157 0
Rv2159c 1 A2421816G Rv2160A −151 — Down 1,2 0.977 0.323
PE_PGRS38 7 A2424864G IGR −18 TSS Down 1 0.973 0
Rv2712c 1 C3025431T IGR −103 P Up 1 0.971 0
vapB22 5 T3137237C IGR −13 P Up 1 0.973 0
yrbE4B 5 G3920109T yrbE4A −47 — Up 1 0.971 0
Rv3695 2 T4137190C IGR −16 — Down 1 0.973 0
Table 1. Putative functional SNPs associated with expression (cis-eQTLs with allele frequencies >5%; 
adjusted p < 0.05). Table showing the candidate transcripts differentially expressed due to SNPs in upstream 
intergenic regions (IGRs) or within the upstream gene. Annotation of the transcript differentially expressed: 
1 – Conserved hypotheticals, 2 – Cell wall and cell processes, 3 – Intermediary metabolism and respiration, 
4 – Lipid metabolism, 5 – Virulence, detoxification, adaptation, 6 – Regulatory proteins, 7 – PE/PPE, 8 – 
information pathways. Distance of the SNP location from the start codon of the transcript is showed as negative 
when it is upstream and positive when it is located within the gene. TSS = Transcriptional Start Site. *Only 
one or two samples from the lineage out of the 3 analysed. **Allele frequency refers to the fraction of strains 
harbouring the SNP in a larger data set (n = 6,218)50; “—“ when not available.
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Methylation analysis. Motif and methylation finding was performed through the Modification and Motif 
Analysis pipeline provided by the SMRT portal (https://github.com/PacificBiosciences/SMRT-Analysis). By ana-
lysing the kinetic variation through the inter-pulse duration ratio (IPD) at each nucleotide in the genome, a large 
Gene Mutation Family
Lineage of strains 
carrying mutation
Allele frequency
Ancient Modern
whiB5 S21G whiB 1.2.2** 0.021 0
Rv0023 G217D 4.9** 0 0.001
Rv0042c L186R* MarR 4.9** 0 0
Rv0144 P36L* tetR 4.9** 0 0
Rv0195 C41STOP LuxR 1.2.2** 0.021 0
Rv0275c S24L tetR 1 0.973 0
iniR E23K 1.2.2** 0.019 0
Rv0377 P302R* LysR 1 0.973 0
Rv0386 L475R* LuxR/UhpA 4.1.1.3 0 0.003
ramB
P91Q 1 0.973 0
T118A 4.9** 0 0.001
Q121R 1 0.973 0
Rv0576 R233H* ArsR 1,2 0.978 0.334
Rv0691c A140T 2 0.003 0.114
Rv0818
P227L* 4.1.1.3 0 0.003
E246K* 4.1.2 0 0.009
narL G169R* 2 0.003 0.147
Rv0890c
E234G*
LuxR
2 0.003 0.111
E303K* 4.1.2 0 0.009
Rv0891c V37G* 1,2,4.1,4.3,4.8 1 0.974
kdpE G60S* KDPD/KDPE 2 0.003 0.111
Rv1219c R11T 1.2.2** 0.148 0
embR
A70S 4.1.2 0 0.009
C110Y 1 0.973 0
Rv1453
D208N 1.1.3 0.230 0
D218N 1.2.2** 0.021 0
P405Q 1,2,4.1,4.3,4.8 1 0.974
Rv1674c E189G* 4.3 0.014 0.281
cmr
V59A
CRP/FNR
1 0.974 0
A125S 1.1.3* 0.072 0
Rv1776c R154S 1.2.2** 0.019 0
blaI L57R 1 0.970 0
mce3R D148Y* tetR 1.1.3** — —
Rv2017 A262E 1,2,4.1,4.3,4.8 0.998 0.973
Rv2160A C155R tetR 1,2 0.977 0.323
zur H64R* 1 0.973 0
Rv2488c D184Y* LuxR 1.2.2** 0.018 0
Rv2621c A110V 2 0.003 0.148
sirR Q131STOP 1 0.973 0
Rv3060c G420D GntR 4.1.2 0 0.009
virS L316R* AraC/XylS 1 0.973 0
Rv3167c P17Q tetR 1 0.973 0
Rv3249c T154A tetR 4.1.1.3 0.003 0.049
whiB4 S2L whiB 1.1.3 0.223 0
Rv3736 G144R* AraC/XylS 1 0.971 0
whiB6 G71D whiB 1.2.2** 0.014 0
Table 2. Non-synonymous variants in transcriptional regulatory genes with eQTL associations, with potential 
functional impairment. Table showing non-synonymous mutations in transcriptional regulatory genes found 
as potential eQTLs. *Sorting Intolerant from tolerant (SIFT) predicted scores (p value) < 0.05 and considered 
to have functional impact; whilst for the others the SIFT software was unable to predict functional effects of 
mutations; **Only one or two samples available from the lineage. Allele frequency refers to the fraction of 
strains harbouring the SNP in a larger data set (n = 6,218)26.
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number of modifications were identified. Only high quality 6-methyl-adenine (m6A) levels were found within 
motifs, where m6A is a well characterised epigenetic regulator in other prokaryotes35,36. The three motifs pre-
viously reported in Mtb15–17 were identified: CTCCAG and GATN4RTAC and their partner motifs (CTGGAG 
and GTAYN4ATC, respectively), and the hemi-methylated CACGCAG. The distribution and numbers of the 
different motifs were similar across the samples regardless of lineage and sub-lineage, with an average number of 
1,934 for CTCCAG, 357 for GATN4RTAC and 813 for CACGCAG. However, the fraction of methylated motifs 
varied across isolates and (sub-)lineage patterns (Supplementary Table S8), consistent with a previous report16. In 
particular, within L4, two sub-lineages patterns were found with methylation in GATN4RTAC and CACGCAG 
motifs. Moreover, the CTCCAG motif was not methylated in either of the two L2 isolates. Among L1, methylation 
in CTCCAG and CACGCAG motifs was absent in some samples. When methylated, the percentage of motifs 
modified across all the samples varied from 50% to ~100%.
To explain the lack of methylation observed in some isolates, the presence of SNPs in the MTases genes was 
investigated. Three SNP mutations were identified: (i) E270A in mamA in L2, (ii) P306L in hsdM in sub-lineages 
4.3, 4.8 and 4.9, and (iii) S253L in mamB in sub-lineage 1.1.3; which have been reported previously to be asso-
ciated with the loss of function of the enzymes15,16 (Supplementary Table S9). Two novel mutations (Q340K and 
G152S) and a deletion (1232delG) were also identified in mamA, potentially associated with the lack of methyla-
tion of CTCCAG in two isolates belonging to L1 and L4. For the remaining samples with an absence of methyla-
tion in any of the three motifs, there were no SNPs uniquely found in these samples that could be correlated with 
the loss of function of the enzyme.
Differential gene expression linked with methylation. In order to understand how the methyla-
tion status of the genes affects their expression, a differential transcription analysis was performed on the L1 
and L4 strains (n = 20) (Supplementary Fig. S1E). The analysis involved stratifying by lineage to overcome the 
lineage-specific transcriptional profiles seen above. L2 was discarded due to the low number of clinical isolates 
represented. Firstly, 5,326 different intragenic methylation sites were used. A linear regression analysis was 
applied to obtain the correlation between methylation status and gene expression level at a whole-genome scale. 
Across L4, 44 genes were found to be differentially expressed (Benjamini-Hochberg (BH) adjusted p < 0.05), 
whose over- or under-expression was potentially associated with their methylation status. Twenty-eight (of the 
44; 63.6%) genes, mostly down-regulated, were deficient in methylation only in the CTCCAG motif in one sam-
ple, which was associated with the presence of the mutation G152S in mamA (Supplementary Fig. S2). These 
genes were enriched for metabolic pathways (p < 0.05). The remaining 16 genes differentially expressed in L4 
were non-methylated in >1 isolate and mostly in the CTCCAG motif (Supplementary Fig. S3). For L1, none 
of the genes that were found to be differentially expressed were significantly associated with methylation sta-
tus. Methylation of the upstream intergenic regions may have a role in gene expression, and we performed a 
lineage-stratified cis-eQTL analysis with the 393 unique methylation sites located within 200 bp upstream from 
the start codons of the genes. In L4, seven eQTLs (BH adjusted p < 0.05) for 8 genes differentially expressed were 
revealed (Table 3, Supplementary Fig. S4), including one located in the predicted promoter region and overlap-
ping with the TSS. Among ancient strains, none of the genes that were found to be differentially expressed were 
significantly associated with methylation of upstream regions.
overlap between eQtLs linked with sNps and methylation. Finally, we assessed whether there is a 
link between the SNPs and methylated motifs associated with the differentially expressed genes identified. To this 
end, we evaluated the degree of overlap between the different associations (Fig. 3). We considered three types of 
association: (i) genes differentially expressed due to SNPs in promoter regions, TSS or within the gene, denoted 
as cis-eQTLs; (ii) genes differentially expressed due to potential impairing mutations in transcriptional regulators 
that are predicted to control their expression, denoted as tr-eQTLs; and (iii) genes differentially expressed as a 
consequence of methylation of either the promoter, TSS, upstream region or the gene, denoted as mod-eQTLs. We 
found that 5 genes with variable transcription were associated with both, mod-eQTLs and cis-eQTLs, and another 
Gene Position strand Motif
Distance from 
start codon (bp) Promoter/TSS
Regulation in non-
methylated samples
Rv0565c 657533 − CTGGAG −63 − Down
ompA 1002711 + CTCCAG −101 − Down
Rv1371 1543277 + CTCCAG −82 − Up
scpB 1938088 + CTCCAG −58 P, TSS Up
moaC3 3710411 − CTCCAG −163 − Up
Rv3324A 3710411 − CTCCAG −32 − Up
Rv3325 3710408 + CTGGAG −25 − Down
PE_PGRS60 4093563 + CTGGAG −69 − Down
Table 3. cis-eQTLs located in upstream intergenic regions linked with methylation in Lineage 4 strains. Table 
showing genes differentially expressed potentially due to the lack of methylation in the upstream region. The 
name of the gene, the position of the eQTL (methylation site), strand, motif, distance of the methylated base 
from start codon of the transcript (negative shown as upstream), prediction of promoter or TSS (P = promoter 
region, TSS = Transcriptional Start Site), and type of regulation of the gene in non-methylated samples is 
shown.
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9 were associated with cis-eQTLs and tr-eQTLs. There was no overlap between genes differentially expressed due 
to tr-eQTLs and mod-eQTLs, and the majority of the genes were uniquely assigned to one of the mechanisms 
responsible for their differential expression.
Discussion
Genetic mutations and variations in gene expression have an important impact on MTC virulence and path-
ogenicity4,5. Previous studies have shown how genomic variants or methylation can affect the level of gene 
expression9,10,17, but have not shown how one analysis may influence another. In this study, for the first time, we 
performed an integrated analysis of the genome, methylome and transcriptome, across 3 major Mtb lineages. We 
have revealed clade-specific differences in the core transcriptomes between ancient and modern strains, as previ-
ously observed9, but in addition our analysis has revealed genes linked to virulence and pathogenicity (e.g. vapBC 
family), drug resistance and efflux pumps (e.g. Rv299423 or iniA and iniB24,25). An eQTL analytical approach 
revealed 5,608 SNPs associated with differential gene expression (a total of 38,949 candidate eQTLs) and rein-
forced the lineage-specific genetic diversity and its effects on transcriptomes. To achieve improved resolution, 
cis-eQTLs based on regions upstream or within the genes differentially expressed were considered. This approach 
revealed ten SNPs within the promoter regions or TSS of genes differentially expressed, as well as others within 
coding regions of the genes, doubling the number of previously reported associations10. Among these variants, 
lineage-specific SNPs were associated with the genes differentially expressed, thereby revealing a potential expla-
nation for the differential core transcription.
The high proportion of non-synonymous mutations present in coding regions in Mtb has been suggested 
to have a functional impact4, with consequences for transcription when found within transcriptional regula-
tors10. In our study, functional impairment was predicted for sixteen of the transcriptional regulators found 
among the 38,949 potential eQTLs, including in sirR and Rv0195 that contained premature stop codons. The 
number of regulators found is likely to be an under-estimate, as databases accessible to SIFT are incomplete, 
leading to no prediction for the vast majority of loci. Most of the potential impairing mutations were found to 
be lineage-specific. In particular, we identified a mutation and an insertion in L1 and L2 strains in Rv2160A, 
which act as a transcriptional activator of the adjacent genes Rv2159c and Rv2161c, with which it likely forms 
an operon29. Similarly, the protein encoded by Rv3167c was predicted to function as a repressor of its contigu-
ous gene Rv3168, over-expressed in ancient samples with the P17Q mutation. Whilst Rv0275c was shown as a 
candidate activator of the adjacent gene Rv0276, and under-expressed in the L1 strains with the S24L mutation, 
consistent with previously reported associations10,31. The analysis of the regulatory networks of the transcriptional 
regulators was performed in order to look for trans-eQTLs, and found 11 of the genes differentially expressed 
from the primary eQTL analysis were regulated by one of the transcriptional regulators harbouring potential 
impairing mutations. Three mutations affecting the function of three anti-sigma factors (rseA, rskA and rsfA) 
were associated with the up-regulation of 6 genes. This result suggests that the functional impairment of sigma 
and anti-sigma factors can be the cause of variable gene expression.
Figure 3. Venn diagram showing the overlap of genes differentially expressed (from the 3,987 investigated) 
associated with the different eQTL types (cis, trans and modified). The numbers represent the number of genes 
differentially expressed associated with the different types of eQTLs: cis-eQTLs, SNPs in promoter regions, 
transcriptional start sites (TSS), upstream (up to −200 bp) or within the gene; tr-eQTLs, potentially impairing 
non-synonymous SNPs located in transcriptional regulators; and mod-eQTLs, methylated bases located either 
within the gene or upstream including promoter regions and TSS.
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Our study confirmed the same motifs and patterns of methylation as previously reported15,16 but in addition 
identified three novel variants (Q340K, 121delG and G152S) in mamA, which could explain the lack of meth-
ylation in the CTCCAG motif in the samples harbouring them. DNA methylation has been hypothesised to 
affect gene expression in bacteria35, and the disruption of mamA in Mtb has been shown to result in altered gene 
expression17. In E. coli it has been suggested that an overrepresented motif in the genome is more likely to be 
involved in gene expression regulation mediated by methylation37. Different hypotheses concerning the control 
of gene expression by dam MTase have been proposed, including regulation by motifs found in promoter38 and 
coding regions39. Further, it has been suggested that DNA methylation is a mechanism of switching regulatory 
states in phase variation systems37. Across the three lineages studied here, CTCCAG was the most abundant motif 
and was predominantly found in coding regions. An investigation of the relationship between the methylation 
status and gene expression levels revealed that the CTCCAG motif has the highest impact. In L4, the differential 
expression of 38 genes was potentially associated with CTCCAG methylation status, compared to 4 and 2 genes 
associated with CACGCAG and GATN4RTAC methylation, respectively. A subset of these genes (28/44), mostly 
down-regulated, were found to be uniquely non-methylated in the sample with the mamA G152S mutation. These 
included genes associated with metabolic pathways or regulatory proteins (e.g. Rv0348, virS or Rv1359), and 
from the pe/ppe families (e.g. PE17, PPE17 or PE_PGRS2). We also found that non-methylated CTCCAG motifs 
in upstream regions and TSS have an effect on gene expression, which is consistent with previous work17. In L1 
no genes significantly associated with methylation were found. Overall our results show that methylation in the 
promoter regions and coding regions is likely to be involved in gene expression, with the CTCCAG motif as the 
main candidate with a role in regulation.
The functional impairment of MTases may have implications in biological processes of the Mtb controlled by 
genes whose expression is affected by the methylation status. This could eventually influence the Mtb’s virulence, 
pathogenicity or drug resistance. For instance, variable methylation status was found to be related to the differ-
ential transcription of genes associated with metabolic pathways, among others, which suggests the potential role 
of methylation on regulation of biological processes related with growth or persistence. However, further work is 
needed to understand how methylation regulates gene expression under different environmental cues including 
those encountered by Mtb inside the host.
In Mtb, virulence and the ability to become drug resistant vary across lineages40,41. Hence, the study of 
lineage-specific transcriptomic profiles and the mechanisms that regulate gene expression can give insights into 
mechanisms underlying these biological differences. Such insights will be useful to identify potential targets for 
the development of new anti-tuberculosis drugs or vaccines. The small sample size is a potential limitation of the 
study, but our integrated analysis has detected known variants and methylated motifs, and putative candidate 
eQTLs for follow-up experiments. Future studies should consider larger sample sizes, including more lineages 
(e.g. other ancient lineages, such as L5 and L6), in order to confirm the candidate associations found in this anal-
ysis. In addition, there is a need for complementary proteomic analyses, to perform a comprehensive integrated 
study of Mtb genetic and epigenetic mechanisms of gene expression control. Overall, our data has identified 
common functional variants that affect transcriptional control, which gives further support to differential patho-
physiology in ancient and modern Mtb lineages.
Materials and Methods
Bacterial strains, DNA and RNA sequencing. All 22 Mtb isolates listed in Supplementary Table S1 were 
sourced from 22 TB patients from Karonga (Malawi) between 2003 and 2009, and cultured in the LSHTM. Mtb 
isolates were grown by liquid culture (in the absence of antimicrobial drugs) from frozen stocks of Lowenstein-
Jensen or liquid cultures derived from patient’s sputum specimens already isolated. Mtb strains were grown to 
mid-log phase (OD = 0.6–0.8) in Middlebrook 7H9 supplemented with 0.05% Tween 80 and 10% albumin-dex-
trose-catalase (ADC) at 37 °C in standing 25 cm2 vented tissue culture flasks and subcultured in 75 cm2 vented 
tissue culture flasks. DNA and RNA were extracted from the same cultures (passage 3–4 from original sputum 
sample) using the phenol-chloroform-isoamyl alcohol method and the trizol method with bead-beating as previ-
ously described42,43. The samples were sequenced at the Genome Institute of Singapore. Single-molecule real time 
(SMRT) sequencing from Pacific Biosciences (PacBio) RSII long read technology was used with the parameter of 
6 hours per SMRTcell (PacBio RS II SMRT Cells 8Pac). The library preparation involved the use of the template 
prep kit 1.0, and the binding chemistry involved the use of DNA/Polymerase binding kit P6. The sequencing kit 
used was the DNA Sequencing Reagent Kit 4.0.
For RNA sequencing, total RNA extracts were run on the Agilent 4200 Tapestation System (Agilent 
Technologies, Santa Clara, CA, USA) using the RNA Tapestation Assay to determine the RNA integrity values. 
TruSeq Stranded mRNA sample preparation was used according to the manufacturer’s instructions for next gen-
eration library preparation. Briefly, library preparation started with purification of mRNA using poly-T oligo 
attached magnetic beads, fragmentation of mRNA, 1st and 2nd strand cDNA synthesis, A-tailing and ligation 
of adapters with multiplex indexes. Samples were enriched with 15 PCR cycles followed by Agencourt AMPure 
XP magnetic bead (Beckman Coulter, Brea, CA, USA) clean up as per the manufacturer’s instructions. Quality 
of cDNA libraries was checked with Agilent D1000 Tapestation Assay (Agilent 4200 Tapestation System, Agilent 
Technologies, Santa Clara, CA, USA). Next generation sequencing was performed using Illumina Hiseq4000 flow 
cell, with 2 × 151 base pair-end runs. PhiX was used as a control.
Bioinformatic and association analysis. PacBio long reads were analysed using the pipelines provided by 
the SMRT Portal software. Briefly, raw sequence data were aligned to the H37Rv (GCA_000195955.2) reference 
genome and small variants (SNPs and indels) were called over the consensus sequences. Single nucleotide poly-
morphisms (SNPs) were used to build the maximum-likelihood phylogenetic tree using RAxML software44. The 
Modification and Motif Analysis pipeline was used then for the methylation study and motif finding. Detection of 
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base modification was performed with a minimum QV score of 30 and coverage of 20-fold. Six-methyl-adenine 
(m6A) was determined within motifs with an inter-pulse duration ratio (IPD ratio) between 3 and 10. Statistical 
enrichment analysis was performed using DAVID software45. Functional impairment prediction for proteins har-
bouring non-synonymous mutations was performed using the Sorting Intolerant from tolerant (SIFT) algorithm46.
Pair-end short reads generated by Illumina HiSeq technology for RNA sequencing were assessed for qual-
ity and trimmed using Trimmomatic v0.3647. High quality reads were mapped to the H37Rv reference genome 
(GCA_000195955.2) using the Burrows-Wheeler Alignment (BWA-mem) v0.7.15 tool48. HTSeq. 0.9.149 was used 
to quantify the number of reads per transcript. Lowly expressed genes were filtered out by a minimum count 
per million (CPM) value of 0.6, equivalent to 10 counts. For differential transcription analysis, counts were then 
normalised using the trimmed mean of M-values normalization (TMM) method50. To compare expression levels 
between ancient and modern strains as well as for the eQTL studies linked with SNPs and methylation, significant 
differences were obtained through linear regression tests. Adjusted p values for multiple testing were calculated 
through the Bonferroni and Benjamini-Hochberg corrections for statistical significance. The prediction of pro-
moter regions was performed using Neural Network Promoter Prediction (http://www.fruitfly.org/seq_tools/
promoter.html). The EGRIN model from the MTB Network Portal32 and the regulatory network map from the TB 
Database33 were used for the study of the association between transcriptional regulators and genes differentially 
expressed. The allele frequencies of variants identified in the eQTL analysis were calculated in an independent set 
of ancient and modern strains using a large published dataset (n = 6,218), described previously26.
Data Availability
All pathogen raw sequencing data is available from the ENA short read archive (accession number PRJEB29197).
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